ArticleBMJ open2013

Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study.

Li Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.